Association of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density in Elderly Women
| Autor: | Vineeth John, Matthew Hnatow, Bo Cao, Smita Saraykar, Catherine G. Ambrose, Nahid J Rianon |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Endocrinology Diabetes and Metabolism Serotonin reuptake inhibitor Osteoporosis 030209 endocrinology & metabolism Bone remodeling 03 medical and health sciences 0302 clinical medicine Bone Density Risk Factors Internal medicine mental disorders Humans Medicine Radiology Nuclear Medicine and imaging Orthopedics and Sports Medicine 030212 general & internal medicine Osteoporosis Postmenopausal Depression (differential diagnoses) Aged Retrospective Studies Femoral neck Bone mineral Depression business.industry digestive oral and skin physiology medicine.disease Cross-Sectional Studies Endocrinology medicine.anatomical_structure Antidepressive Agents Second-Generation Antidepressant Female business Body mass index Selective Serotonin Reuptake Inhibitors |
| Zdroj: | Journal of Clinical Densitometry. 21:193-199 |
| ISSN: | 1094-6950 |
| DOI: | 10.1016/j.jocd.2017.05.016 |
| Popis: | Depression and osteoporosis are 2 common comorbidities in geriatric patients. There are concerns about the deleterious effects of selective serotonin reuptake inhibitor (SSRI) antidepressant use on bone mineral density (BMD). We examined the association between SSRI use and BMD in elderly women (≥65 yr) referred to a geriatric osteoporosis clinic for bone health evaluation. Cross-sectional analyses using the general linear model were performed on data collected retrospectively from August 2010 to April 2015. A total of 250 women were seen during the study period. Of these, 140 women had complete data on BMD measurements: 22 (15.7%) used an SSRI and 118 (84.3%) did not. The 2 groups, SSRI users and SSRI nonusers, did not differ significantly across any of the covariates tested (age, ethnicity, body mass index, and past and present osteoporosis treatment medications). After adjusting for covariates, there was no difference in the BMDs at the femoral neck (p = 0.887) or the spine (p = 0.275) between the 2 groups. Similarly, no difference was seen in the T-scores between SSRI users and nonusers at the femoral neck (p = 0.924) or at the spine level (p = 0.393). Our study did not show an association between SSRI use and BMD among elderly women referred for bone health evaluation. Other studies in the literature have been inconclusive, and therefore, robust longitudinal studies are needed to further assess the interaction between SSRI use and predictors of fracture such as BMD, bone turnover markers, and genes involved in bone turnover. Until then, clinicians should closely monitor the bone health of long-term SSRI users. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|